228 related articles for article (PubMed ID: 24920125)
1. Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.
Geoffrion M; Du X; Irshad Z; Vanderhyden BC; Courville K; Sui G; D'Agati VD; Ott-Braschi S; Rabbani N; Thornalley PJ; Brownlee M; Milne RW
Physiol Rep; 2014 Jun; 2(6):. PubMed ID: 24920125
[TBL] [Abstract][Full Text] [Related]
2. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
[TBL] [Abstract][Full Text] [Related]
3. A Glyoxalase-1 Knockdown Does Not Have Major Short Term Effects on Energy Expenditure and Atherosclerosis in Mice.
Wortmann M; Hakimi M; Fleming T; Peters AS; Sijmonsma TP; Herzig S; Nawroth PP; Böckler D; Dihlmann S
J Diabetes Res; 2016; 2016():2981639. PubMed ID: 26788517
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.
Giacco F; Du X; D'Agati VD; Milne R; Sui G; Geoffrion M; Brownlee M
Diabetes; 2014 Jan; 63(1):291-9. PubMed ID: 24062246
[TBL] [Abstract][Full Text] [Related]
5. Glyoxalase 1 expression is downregulated in preimplantation blastocysts of diabetic rabbits.
Seeling T; Haucke E; Navarrete Santos A; Grybel KJ; Gürke J; Pendzialek SM; Schindler M; Simm A; Navarrete Santos A
Reprod Domest Anim; 2019 Sep; 54 Suppl 3():4-11. PubMed ID: 31512318
[TBL] [Abstract][Full Text] [Related]
6. Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?
Jack MM; Ryals JM; Wright DE
Exp Neurol; 2012 Mar; 234(1):62-9. PubMed ID: 22201551
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.
Yao D; Brownlee M
Diabetes; 2010 Jan; 59(1):249-55. PubMed ID: 19833897
[TBL] [Abstract][Full Text] [Related]
9. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.
Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ
Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499
[TBL] [Abstract][Full Text] [Related]
10. Deleterious Effect of Advanced CKD on Glyoxalase System Activity not Limited to Diabetes Aetiology.
Pácal L; Chalásová K; Pleskačová A; Řehořová J; Tomandl J; Kaňková K
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783710
[TBL] [Abstract][Full Text] [Related]
11. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lu Z; Zhang X; Li Y; Jin J; Huang Y
J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in Glyoxalase I Gene Are Not Associated with Glyoxalase I Expression in Whole Blood or Markers of Methylglyoxal Stress: The CODAM Study.
Maasen K; Hanssen NMJ; van der Kallen CJH; Stehouwer CDA; van Greevenbroek MMJ; Schalkwijk CG
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33540757
[TBL] [Abstract][Full Text] [Related]
14. Effect of metformin treatment in patients with type 2 diabetes with respect to glyoxalase 1 activity in atherosclerotic lesions.
Peters AS; Wortmann M; Fleming TH; Nawroth PP; Bruckner T; Böckler D; Hakimi M
Vasa; 2019 Mar; 48(2):186-192. PubMed ID: 30421661
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.
Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564
[TBL] [Abstract][Full Text] [Related]
16. Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.
Degaffe GH; Vander Jagt DL; Bobelu A; Bobelu J; Neha D; Waikaniwa M; Zager P; Shah VO
J Diabetes Complications; 2008; 22(4):267-72. PubMed ID: 18413187
[TBL] [Abstract][Full Text] [Related]
17. Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation.
Jo-Watanabe A; Ohse T; Nishimatsu H; Takahashi M; Ikeda Y; Wada T; Shirakawa J; Nagai R; Miyata T; Nagano T; Hirata Y; Inagi R; Nangaku M
Aging Cell; 2014 Jun; 13(3):519-28. PubMed ID: 24612481
[TBL] [Abstract][Full Text] [Related]
18. Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Pugliese G
Diabetologia; 2015 Apr; 58(4):845-53. PubMed ID: 25471794
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N; Thornalley PJ
Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway.
Luo M; Sun Q; Zhao H; Tao J; Yan D
Med Sci Monit; 2019 Oct; 25():7966-7975. PubMed ID: 31645538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
